<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Open Science Publishers LLP</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">189</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url"> http://dx.doi.org/10.31782/IJMPS.2018.8201</article-id><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>Investigating the Synergistic In-vitro Anti-inflammatory Potentials of Standardized Fruit Extract of Eugenia jambolana and Standardized Fruit Extract Piper nigrum Combinations&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kadawla</surname><given-names>Mamta</given-names></name></contrib><contrib contrib-type="author"><name><surname>Singla</surname><given-names>Neelam</given-names></name></contrib></contrib-group><pub-date pub-type="ppub"><day>10</day><month>08</month><year>2018</year></pub-date><volume/><issue/><fpage>1</fpage><lpage>4</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>After searching PubMed, Google Scholar, Scopus, and other pharmaceutical databases, it was discovered that no combined anti-inflammatory viewpoints of Eugenia jambolana fruit extract and Piper nigrum fruit extract have been published in an in vitro technique (human red blood cells, HRBC). To investigate the synergistic activity, the E. jambolana standardized fruit extract (EJSFE) and P. nigrum standardized fruit extract (PNSFE) were screened together. EJSFE gave 27.23 percent membrane stabilization/protection in HRBCs at a concentration of 250 __ampersandsignmu;g/mL, whereas PNSFE supplied 32.31 percent membrane stabilization/protection in HRBCs. The anti-inflammatory impact was raised to 58.63 percent when the extracts EJSFE and PNSFE were evaluated combined (at a concentration of 250 __ampersandsignmu;g/mL each). When both extracts were administered at the same time, the anti-inflammatory effect increased by 25 percent to 30 percent. Flavonoids, phenols, tannins, and alkaloids are phytoconstituents present in plant material that play a significant role in mediating anti-inflammatory effects by blocking several inflammatory enzymes. The extract__ampersandsignrsquo;s strong phenolic, tannin, and flavonoid content worked together to stabilize the HRBC membrane in a synergistic way. This paper will pave the way for future research into the creation of novel herbal formulations for the treatment of acute and chronic inflammation.&#13;
</p></abstract><kwd-group><kwd> Eugenia jambolana</kwd><kwd> Piper nigrum</kwd><kwd> Extract</kwd><kwd> anti-inflammatory</kwd><kwd> HRBC Method</kwd><kwd> Phytoconstituents</kwd></kwd-group></article-meta></front></article>
